Senators Thom Tillis (R-NC) and Gary Peters (D-MI) introduced the Radiation Oncology Case Rate (ROCR) Value-Based Program Act ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.

Institutional peer review led to recommended changes in more than one-quarter of radiotherapy treatment plans, according to ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival outcomes of radical prostatectomy versus dose-escalated radiation with ADT ...

Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Black women tend to get more aggressive uterine cancers than White women. But this is only part of the story, investigators ...